Chlorzoxazone Tablet
Product Images NDC 0254-2005

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlorzoxazone (NDC 0254-2005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chlorzoxazone Tablets Usp 1

Chemical structure of chlorzoxazone, showing a chlorinated benzene ring fused to an oxazolone moiety.*

FDA Label Image

Chlorzoxazone Tablets Usp 2

Label for Chlorzoxazone Tablets USP 375 mg oral tablets by Par Pharmaceutical. The label indicates a bottle containing 100 tablets, prescription only. Storage instructions specify 20° to 25°C controlled room temperature. Distributed by Par Pharmaceutical in New York and manufactured by Par Formulations Private Limited in India. The label includes a barcode and regulatory statements about dispensing and storage.*

FDA Label Image

Chlorzoxazone Tablets Usp 3

Label for Chlorzoxazone Tablets USP 750 mg oral tablets, containing 100 tablets per bulk container. The label indicates prescription use only and is distributed by Par Pharmaceutical. Storage instructions specify 20° to 25°C (68° to 77°F). The label includes a barcode and states the product is made in India by Par Formulations Private Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.